What is China Resources Boya Bio-pharmaceutical Group Co Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. China Resources Boya Bio-pharmaceutical Group Co's Average Total Inventories for the quarter that ended in Mar. 2025 was ¥989 Mil. China Resources Boya Bio-pharmaceutical Group Co's Revenue for the
three
months ended in Mar. 2025 was ¥536 Mil.
China Resources Boya Bio-pharmaceutical Group Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 1.85.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
China Resources Boya Bio-pharmaceutical Group Co's Days Inventory for the
three
months ended in Mar. 2025 was 364.67.
Inventory Turnover measures how fast the company turns over its inventory within a year.
China Resources Boya Bio-pharmaceutical Group Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.25.
China Resources Boya Bio-pharmaceutical Group Co Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Resources Boya Bio-pharmaceutical Group Co Inventory-to-Revenue Chart
China Resources Boya Bio-pharmaceutical Group Co Annual Data
Competitive Comparison of China Resources Boya Bio-pharmaceutical Group Co's Inventory-to-Revenue
For the Biotechnology subindustry, China Resources Boya Bio-pharmaceutical Group Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Boya Bio-pharmaceutical Group Co's Inventory-to-Revenue Distribution in the Biotechnology Industry
China Resources Boya Bio-pharmaceutical Group Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
China Resources Boya Bio-pharmaceutical Group Co's Days Inventory for the
three
months ended in Mar. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Boya Bio-pharmaceutical Group Co Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
China Resources Boya Bio-pharmaceutical Group Co Business Description
China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300294 has been successfully added to your 